BET 1: is long-term Rivaroxaban superior to Warfarin in pulmonary embolism?
Emerg Med J. 2015 Nov;32(11):895-8
Authors: Morgan C, Body R
Abstract
A short cut review was carried out to establish whether Rivaroxaban is superior to warfarin in the management of pulmonary embolism. Three studies were directly relevant to the question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these papers are tabulated. The clinical bottom line is that Rivaroxaban is a promising alternative to warfarin in the management of pulmonary embolism.
PMID: 26490283 [PubMed - in process]